On March 5, 2025, the Colorado state legislature introduced Senate Bill (SB) 25-198, aiming to expand Colorado’s licensed hospital notice requirements for material healthcare transactions and impose notification and...more
4/2/2025
/ Acquisitions ,
Colorado ,
Disclosure Requirements ,
Healthcare ,
Healthcare Facilities ,
Healthcare Reform ,
Hospitals ,
Mergers ,
Notice Requirements ,
Proposed Legislation ,
Regulatory Requirements ,
State Attorneys General
On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 (GLP-1) medication, marking the shortage as “resolved” for all presentations of the...more
On February 6, 2025, the Illinois state legislature introduced Senate Bill (SB) 1998, aiming to implement an additional layer of scrutiny to covered transactions that are financed by private equity groups or hedge funds. The...more
3/5/2025
/ Acquisitions ,
Antitrust Division ,
Antitrust Provisions ,
Consent ,
Healthcare ,
Healthcare Facilities ,
Illinois ,
Mergers ,
Private Equity ,
Regulatory Requirements ,
State and Local Government ,
State Attorneys General
On January 21, 2025, the Washington state legislature introduced Senate Bill (SB) 5387, aiming to codify a restrictive state prohibition on the corporate practice of healthcare, commonly referred to as a corporate practice of...more
3/3/2025
/ Compliance ,
Corporate Practice of Medicine ,
Enforcement Actions ,
Health Care Providers ,
Healthcare ,
Legislative Agendas ,
New Legislation ,
Regulatory Agenda ,
Regulatory Requirements ,
State Legislatures ,
Telemedicine ,
Washington
On February 12, 2025, Senator Christopher Cabaldon introduced California Senate Bill (SB) 351, which would codify and strengthen California’s existing corporate practice of medicine (CPOM) and corporate practice of dentistry...more
3/3/2025
/ California ,
Corporate Governance ,
Dentists ,
Health Care Providers ,
Healthcare ,
Legislative Agendas ,
New Legislation ,
Physicians ,
Private Equity ,
Regulatory Requirements ,
State Legislatures
On January 10, 2025, the Oregon Legislative Counsel introduced Senate Bill (SB) 951, aiming to modernize Oregon’s corporate practice of medicine (CPOM) doctrine. If enacted, SB 951would prohibit management services...more
2/17/2025
/ Corporate Governance ,
Healthcare ,
Legislative Agendas ,
New Legislation ,
Non-Disclosure Agreement ,
Oregon ,
Physicians ,
Proposed Legislation ,
Regulatory Requirements ,
Restrictive Covenants ,
State and Local Government ,
State Legislatures ,
Telehealth
The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit. The flexibilities were...more
11/19/2024
/ Controlled Substances ,
Coronavirus/COVID-19 ,
DEA ,
Department of Health and Human Services (HHS) ,
Extensions ,
Healthcare ,
Prescription Drugs ,
Public Health Emergency ,
Regulatory Agenda ,
Telehealth ,
Telemedicine ,
Temporary Regulations
KEY UPDATE -
Illinois enacted HB 5087, which significantly limits physical therapists’ ability to provide telehealth services to patients in the state. As enacted, these new provisions become effective on January 1, 2025....more
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists, and technology companies that deliver and facilitate...more
10/17/2024
/ Digital Health ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Insurance Industry ,
Legislative Agendas ,
Life Sciences ,
Medicaid ,
Proposed Legislation ,
Reimbursements ,
Rulemaking Process ,
State and Local Government ,
Telehealth ,
Telemedicine
On October 3, 2024, the US Food and Drug Administration (FDA) revised its shortage categorization of tirzepatide, a glucagon-like peptide 1 (GLP-1) medication, marking the shortage as “resolved” for all presentations of the...more
10/10/2024
/ Drug Compounding ,
Food and Drug Administration (FDA) ,
Goods or Services ,
Healthcare ,
Life Sciences ,
Patient Access ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Supply Chain ,
Supply Shortages
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate...more
8/19/2024
/ Digital Health ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Interstate Compacts ,
Legislative Agendas ,
Life Sciences ,
Regulatory Requirements ,
Rulemaking Process ,
State and Local Government ,
Telehealth ,
Telemedicine
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate...more
7/1/2024
/ Digital Health ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Interstate Compacts ,
Legislative Agendas ,
Regulatory Agenda ,
Rulemaking Process ,
State and Local Government ,
Technology Sector ,
Telehealth ,
Telemedicine
In California, pending Assembly Bill 3129 (the Act) could severely limit the ability of digital health companies to grow and operate in the state by prohibiting arrangements between physician, psychiatric, and dental...more
6/21/2024
/ California ,
Digital Health ,
Healthcare ,
Investment ,
Investors ,
Patient Access ,
Pending Legislation ,
Private Equity ,
Telehealth ,
Telemedicine ,
Venture Capital
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate...more
5/14/2024
/ Digital Health ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Interstate Compacts ,
Legislative Agendas ,
Life Sciences ,
Proposed Legislation ,
Regulatory Requirements ,
Rulemaking Process ,
State and Local Government ,
Telehealth ,
Telemedicine
The Physician Practice Management (PPM) and ASC Symposium 2024 is the destination event for PPM and ASC industry leaders and health industry investors. Join us as we deliver actionable insights on the state of the market and...more
5/3/2024
/ Ambulatory Surgery Centers ,
Artificial Intelligence ,
Business Development ,
Business Opportunities ,
Continuing Legal Education ,
Events ,
Exit Strategies ,
Fraud and Abuse ,
Health Care Providers ,
Healthcare Facilities ,
Investment Banks ,
Investment Opportunities ,
Investors ,
Joint Venture ,
Medicare ,
Mental Health ,
Partnerships ,
Physicians ,
Prior Authorization ,
Privacy Laws ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Reimbursements ,
Risk Management ,
Substance Abuse ,
Telehealth ,
Value-Based Care
In an apparent attempt to shield physician practices from perceived abuses of close association with physician practice management (PPM) companies, a pending Oregon law could undermine a broad range of structures and...more
2/19/2024
/ Acquisitions ,
Corporate Governance ,
Internal Controls ,
Merger Controls ,
Mergers ,
Oregon ,
Pending Litigation ,
Physician-Owned Distributors ,
Physician-Owned Hospitals ,
Physicians ,
Proposed Legislation ,
State Legislatures
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate...more
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate...more
11/20/2023
/ Digital Health ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Interstate Compacts ,
Licensing Rules ,
Life Sciences ,
Medicaid ,
Medical Reimbursement ,
New Legislation ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Technology ,
Telehealth
The United States Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) have further extended flexibilities that allow providers to prescribe controlled substances...more
10/9/2023
/ Controlled Substances ,
Coronavirus/COVID-19 ,
DEA ,
Extensions ,
Healthcare ,
Prescription Drugs ,
Public Health Emergency ,
SAMHSA ,
Telehealth ,
Telemedicine ,
Temporary Regulations
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate...more
9/29/2023
/ Digital Health ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Medicaid ,
New Legislation ,
New Regulations ,
Pharmaceutical Industry ,
Pharmacist ,
Proposed Rules ,
Regulatory Agenda ,
Technology Sector ,
Telehealth ,
Telemedicine
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate...more
Trending in Telehealth is a new series from the McDermott digital health team in which we highlight state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies,...more
6/28/2023
/ Digital Health ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Innovative Technology ,
Legislative Agendas ,
Life Sciences ,
Medical Marijuana ,
Mental Health ,
Payment Systems ,
Pilot Programs ,
Proposed Legislation ,
State and Local Government ,
Telehealth ,
Telemedicine
In this session, Patrick Zanayad, a partner in McDermott’s Healthcare practice group, moderated a panel of senior healthcare executives that featured a wide-ranging discussion of the current state of orthopedics and physical...more
The US Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) are extending telehealth flexibilities that allow providers to prescribe controlled substances. While the...more
5/11/2023
/ Controlled Substances ,
Controlled Substances Act ,
DEA ,
Department of Health and Human Services (HHS) ,
Health Care Providers ,
OIG ,
Public Health Emergency ,
Rulemaking Process ,
SAMHSA ,
Substance Abuse ,
Telehealth ,
Telemedicine
The unique business opportunities created by digital health companies can carry heightened regulatory risks. As investors increase their focus on the digital health sector and as digital health companies engage in more...more
11/30/2021
/ Business Opportunities ,
Capital Raising ,
Data Rights ,
Digital Health ,
Health Care Providers ,
Investment Firms ,
Investors ,
Physicians ,
Regulatory Requirements ,
Reimbursements ,
Risk Management ,
Startups ,
Venture Funding ,
Webinars